Temsirolimus is a selective mTOR inhibitor, it binds to the intracellular protein FKBP-12, and the complex FKBP-12/temsirolimus binds to mTOR, which controls the division of cancer cells, thus inhibiting its activity. Here, MTOR is linked to cancer.